MX2023009743A - Metodos y sistemas para analisis de datos cromatograficos. - Google Patents

Metodos y sistemas para analisis de datos cromatograficos.

Info

Publication number
MX2023009743A
MX2023009743A MX2023009743A MX2023009743A MX2023009743A MX 2023009743 A MX2023009743 A MX 2023009743A MX 2023009743 A MX2023009743 A MX 2023009743A MX 2023009743 A MX2023009743 A MX 2023009743A MX 2023009743 A MX2023009743 A MX 2023009743A
Authority
MX
Mexico
Prior art keywords
systems
methods
data analysis
chromatography data
process controls
Prior art date
Application number
MX2023009743A
Other languages
English (en)
Inventor
Nathan Mao
Eric Shierly
Bernhard Schilling
Scott Carver
Stefanie Mcdermott
John Mattila
Hanne Bak
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60269959&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2023009743(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2023009743A publication Critical patent/MX2023009743A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8693—Models, e.g. prediction of retention times, method development and validation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8603—Signal analysis with integration or differentiation
    • G01N30/8617—Filtering, e.g. Fourier filtering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/889—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 monitoring the quality of the stationary phase; column performance

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Las modalidades de la presente invención están dirigidas a métodos y sistemas para evaluar la integridad de columnas, sistemas y procesos cromatográficos. Los métodos y sistemas pueden comprender uno o más de extraer un bloque y combinación de señales para análisis, efectuar un análisis de transición, efectuar uno o más controles estadísticos de proceso y/o implementar controles en procesos sobre la base de los controles estadísticos de proceso.
MX2023009743A 2016-10-25 2019-04-12 Metodos y sistemas para analisis de datos cromatograficos. MX2023009743A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662412563P 2016-10-25 2016-10-25

Publications (1)

Publication Number Publication Date
MX2023009743A true MX2023009743A (es) 2023-08-30

Family

ID=60269959

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2019004316A MX2019004316A (es) 2016-10-25 2017-10-25 Metodos y sistemas para analisis de datos cromatograficos.
MX2023009744A MX2023009744A (es) 2016-10-25 2019-04-12 Metodos y sistemas para analisis de datos cromatograficos.
MX2023009743A MX2023009743A (es) 2016-10-25 2019-04-12 Metodos y sistemas para analisis de datos cromatograficos.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2019004316A MX2019004316A (es) 2016-10-25 2017-10-25 Metodos y sistemas para analisis de datos cromatograficos.
MX2023009744A MX2023009744A (es) 2016-10-25 2019-04-12 Metodos y sistemas para analisis de datos cromatograficos.

Country Status (18)

Country Link
US (4) US10613063B2 (es)
EP (2) EP3532838B1 (es)
JP (3) JP7102401B2 (es)
KR (2) KR102564393B1 (es)
CN (2) CN114858957A (es)
AU (2) AU2017350807B2 (es)
BR (1) BR112019006689A2 (es)
CA (1) CA3039788A1 (es)
DK (1) DK3532838T3 (es)
EA (1) EA201990986A1 (es)
ES (1) ES2924060T3 (es)
HU (1) HUE059631T2 (es)
IL (4) IL312194A (es)
MX (3) MX2019004316A (es)
PL (1) PL3532838T3 (es)
SG (1) SG11201902667UA (es)
WO (1) WO2018081203A1 (es)
ZA (1) ZA201902257B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108780065B (zh) * 2016-03-14 2021-03-19 株式会社岛津制作所 质谱分析数据解析装置、方法及非暂时性计算机可读介质
AU2017350807B2 (en) * 2016-10-25 2022-07-07 Regeneron Pharmaceuticals, Inc. Methods and systems for chromatography data analysis
WO2018098502A1 (en) * 2016-11-28 2018-05-31 Board Of Regents, The University Of Texas System Systems, methods and devices for width-based analysis of peak traces
ES2914987T3 (es) * 2018-04-20 2022-06-20 Janssen Biotech Inc Calificación de columnas de cromatografía en métodos de fabricación para producir composiciones de anticuerpos anti-IL12/IL23
CN109100441B (zh) * 2018-08-23 2021-05-07 西南科技大学 一种液相色谱曲线去除脉冲干扰的方法
JP6791216B2 (ja) * 2018-08-28 2020-11-25 横河電機株式会社 監視プログラム、監視装置、及び監視システム
CN110988232A (zh) * 2019-11-28 2020-04-10 南通乐尔环保科技有限公司 一种色谱基线降噪方法及其装置
JP7452186B2 (ja) 2020-03-30 2024-03-19 東ソー株式会社 クロマトグラフの運転状態の推定方法
EP4136442A1 (en) * 2020-04-14 2023-02-22 Regeneron Pharmaceuticals, Inc. Ultraviolet monitoring of chromatography performance by orthogonal partial least squares
JP2022091322A (ja) * 2020-12-09 2022-06-21 株式会社島津製作所 液体クロマトグラフのｐＨ管理システムおよびプログラム
CN112730712B (zh) * 2020-12-31 2022-06-07 杭州谱育科技发展有限公司 提高lc-ms数据信噪比的方法
CN113321817A (zh) * 2021-07-06 2021-08-31 青岛科技大学 一种纳米木质素制备过程关键变量的分析方法
KR20240046607A (ko) * 2021-09-28 2024-04-09 메르크 파텐트 게엠베하 연속 크로마토그래피 작업 동안의 크로마토그래피 수지의 모니터링 방법
CN115825313B (zh) * 2023-02-22 2023-04-11 华谱科仪(北京)科技有限公司 色谱信息检测方法、装置、电子设备和计算机可读介质

Family Cites Families (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937188A (en) 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
US4801726A (en) 1986-04-15 1989-01-31 Northeastern University Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
US5190864A (en) 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
JPH07111423B2 (ja) * 1986-10-01 1995-11-29 株式会社日立製作所 クロマトグラフのデ−タ処理方法
JPS6486060A (en) * 1987-09-29 1989-03-30 Shimadzu Corp Analysis data processor
US5412083A (en) 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
WO1996025425A1 (en) 1995-02-16 1996-08-22 Massachusetts Health Research Institute, Inc. Purified tetanus toxoid and toxin
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3180010B2 (ja) * 1995-10-13 2001-06-25 株式会社日立製作所 クロマトグラフ分析装置
KR19990056559A (ko) * 1997-12-29 1999-07-15 윤종용 노이즈 감소방법 및 그 장치
US6441160B2 (en) 1998-05-11 2002-08-27 Tosoh Corporation Separating plasmids from contaminants using hydrophobic or hydrophobic and ion exchange chromatography
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
EP2116265B1 (en) 2000-10-12 2020-12-23 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
US7101982B2 (en) 2001-03-30 2006-09-05 Immunex Corporation Control of ph transitions during chromatography
WO2004020971A2 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
NZ563078A (en) 2002-09-13 2009-07-31 Biogen Idec Inc Method of purifying polypeptides by simulated moving bed chromatography
US20060257972A1 (en) 2003-03-31 2006-11-16 Takashi Ishihara Purification of human monoclonal antibody and human polyclonal antibody
JP5091476B2 (ja) 2003-06-27 2012-12-05 バイオジェン・アイデック・エムエイ・インコーポレイテッド 均質な抗体溶液の生成のための疎水性相互作用クロマトグラフィーまたはヒンジ領域改変の使用
CA2542951C (en) 2003-10-24 2016-08-30 Abhinav A. Shukla Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
WO2005082483A1 (en) 2004-02-27 2005-09-09 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
SE0400886D0 (sv) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
WO2006020622A1 (en) 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
RU2389552C2 (ru) 2004-10-21 2010-05-20 Джи-И Хелткер Байо-Сайенсиз АБ Способ очистки антител
EP1877438A2 (en) 2005-02-02 2008-01-16 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a vegf inhibitor
US20080299671A1 (en) 2005-12-02 2008-12-04 Ge Healthcare Bio-Sciences Ab Hydrophobic Interaction Chromatography
CN101410137A (zh) 2006-03-28 2009-04-15 霍夫曼-拉罗奇有限公司 抗-igf-1r人单克隆抗体制剂
BRPI0709726A2 (pt) 2006-04-05 2011-07-26 Abbott Biotechnology Ltd. purificaÇço de anticorpo
WO2007149334A2 (en) 2006-06-16 2007-12-27 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations suitable for intravitreal administration
WO2008028974A1 (en) 2006-09-08 2008-03-13 Novo Nordisk A/S Methods of optimizing chromatographic separation of polypeptides
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
US20080299545A1 (en) 2007-03-06 2008-12-04 Shuyuan Zhang Chromatographic methods for assessing adenovirus purity
US8003364B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia viruses using hydrophobic interaction chromatography
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
EP2252952B1 (en) * 2008-01-25 2019-03-13 Biogen MA Inc. Automated system and method for monitoring chromatography column performance, and applications thereof
US7897405B2 (en) * 2008-02-11 2011-03-01 Thermo Finnigan Llc Method for identifying the elution time of an analyte
US20090277254A1 (en) 2008-05-09 2009-11-12 Medlmmune, Llc Methods of improving packed-bed chromatography performance
WO2010019814A1 (en) * 2008-08-15 2010-02-18 Biogen Idec Ma Inc. Methods for evaluating chromatography column performance
US20100069617A1 (en) 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
SG10201702922VA (en) 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
JP2012526121A (ja) 2009-05-04 2012-10-25 アボツト・バイオテクノロジー・リミテツド ヒト抗ｔｎｆアルファ抗体の安定した高蛋白質濃度製剤
KR101812813B1 (ko) 2009-06-16 2017-12-27 젠자임 코포레이션 재조합 ａａｖ 벡터에 대한 개선된 정제 방법
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
DK3037104T3 (da) 2009-10-20 2020-07-20 Abbvie Inc Isolering og renselse af anti-il-13 antistoffer ved brug af protein a beslægtet kromatografi
US8246833B2 (en) 2009-12-17 2012-08-21 Ge Healthcare Bio-Sciences Ab Chromatography column and maintenance method
CA2787897A1 (en) 2010-02-12 2011-08-18 Dsm Ip Assets B.V. Single unit antibody purification
CN102906851B (zh) * 2010-06-10 2015-09-16 国际商业机器公司 分析质谱的方法及***
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
EP2637690B1 (en) 2010-11-11 2016-09-21 AbbVie Biotechnology Ltd HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS
JP6088435B2 (ja) 2010-12-15 2017-03-01 バクスアルタ ゲーエムベーハー 導電率グラディエントを用いる溶出液収集
US9943594B2 (en) 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
EP2773439A4 (en) 2011-10-31 2015-07-01 Merck Sharp & Dohme CHROMATOGRAPHY METHOD FOR DECOMPOSING HETEROGENEOUS ANTIBODY AGGREGATES
WO2013074557A1 (en) 2011-11-14 2013-05-23 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a
WO2013078170A1 (en) 2011-11-21 2013-05-30 Genentech, Inc. Purification of anti-c-met antibodies
WO2013089477A1 (en) 2011-12-15 2013-06-20 Hanwha Chemical Corporation A method of antibody purification
JP6077568B2 (ja) * 2012-01-16 2017-02-08 レコ コーポレイションＬｅｃｏ Ｃｏｒｐｏｒａｔｉｏｎ クロマトグラフィーシステムでのデータを処理するためのシステム及び方法
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
WO2013177118A2 (en) 2012-05-21 2013-11-28 Abbvie Inc. Novel purification of non-human antibodies using protein a affinity chromatography
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US8941405B2 (en) 2012-08-03 2015-01-27 International Business Machines Corporation FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
EP2879691B1 (en) 2012-08-06 2019-03-27 Biogen MA Inc. Methods for inactivating enveloped viruses
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
WO2014100143A2 (en) 2012-12-20 2014-06-26 Medimmune, Llc Liquid antibody formulation with improved aggregation properties
BR112015021495A2 (pt) 2013-03-08 2017-07-18 Genzyme Corp fabricação contínua integrada de substâncias de droga de proteína terapêutica
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP2836515A1 (en) 2013-03-14 2015-02-18 AbbVie Inc. Low acidic species compositions and methods for producing and using the same
TW201940691A (zh) 2013-03-15 2019-10-16 美商艾爾德生物製藥股份有限公司 抗體純化及純度監測
WO2014145208A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Hydrophobic interaction protein chromatography under no-salt conditions
PL2981822T4 (pl) 2013-05-06 2021-07-12 Scholar Rock, Inc. Kompozycje i sposoby modulacji czynnika wzrostu
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
TWI682780B (zh) 2013-05-30 2020-01-21 美商再生元醫藥公司 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
KR101569783B1 (ko) 2013-06-05 2015-11-19 한화케미칼 주식회사 항체의 정제 방법
US9150938B2 (en) 2013-06-12 2015-10-06 Orochem Technologies, Inc. Tagatose production from deproteinized whey and purification by continuous chromatography
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
EP3041593A4 (en) 2013-09-05 2017-08-30 F. Hoffmann-La Roche AG Method for chromatography reuse
EP4163633A1 (en) 2013-09-13 2023-04-12 F. Hoffmann-La Roche AG Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
CA2921999C (en) 2013-09-13 2023-03-21 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
JP2016538267A (ja) 2013-10-25 2016-12-08 メディミューン，エルエルシー 抗体精製
US10115576B2 (en) * 2013-12-12 2018-10-30 Waters Technologies Corporation Method and an apparatus for analyzing a complex sample
JP6260351B2 (ja) * 2014-03-04 2018-01-17 株式会社島津製作所 クロマトグラフ用データ処理装置及びデータ処理方法
JO3701B1 (ar) 2014-05-23 2021-01-31 Regeneron Pharma مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
JP2017536391A (ja) 2014-12-02 2017-12-07 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｉｌ−６ｒアンタゴニストを投与することによってドライアイ疾患を治療するための方法
WO2016118707A1 (en) 2015-01-21 2016-07-28 Oncobiologics, Inc. Modulation of charge variants in a monoclonal antibody composition
TWI710573B (zh) 2015-01-26 2020-11-21 美商再生元醫藥公司 抗伊波拉病毒醣蛋白之人類抗體
CN104748764B (zh) * 2015-04-01 2017-05-24 清华大学 一种声场可视化***中声像平面的空间角度标定方法
TWI756187B (zh) 2015-10-09 2022-03-01 美商再生元醫藥公司 抗ｌａｇ３抗體及其用途
EA201891495A1 (ru) 2015-12-22 2018-11-30 Ридженерон Фармасьютикалз, Инк. Биспецифические анти-cd20/анти-cd3 антитела для лечения острого лимфобластного лейкоза
HRP20231156T1 (hr) 2015-12-22 2024-01-05 Regeneron Pharmaceuticals, Inc. Kombinacija anti-pd-1 antitijela i bispecifičnih anti-cd20/anti-cd3 antitijela za liječenje raka
EP3184119A1 (en) 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
US10353868B2 (en) * 2016-04-11 2019-07-16 RMC Pharmaceutical Solutions, Inc. Methods and systems for event based notifications
KR102461234B1 (ko) 2016-06-14 2022-10-28 바이오젠 엠에이 인코포레이티드 올리고뉴클레오타이드의 정제를 위한 소수성 상호 작용 크로마토그래피
WO2018027195A1 (en) 2016-08-05 2018-02-08 Abbvie Biotherapeutics Inc. Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
AU2017350807B2 (en) * 2016-10-25 2022-07-07 Regeneron Pharmaceuticals, Inc. Methods and systems for chromatography data analysis
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
US11697670B2 (en) 2017-08-22 2023-07-11 Biogen Ma Inc. Methods for purifying antibodies having reduced high molecular weight aggregates
WO2019178489A1 (en) 2018-03-16 2019-09-19 Bristol-Myers Squibb Company Metabolic enzyme activity and disulfide bond reduction during protein production
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses
WO2019191416A1 (en) 2018-03-29 2019-10-03 Bristol-Myers Squibb Company Methods of purifying monomeric monoclonal antibodies
EP3810650A1 (en) 2018-06-19 2021-04-28 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
TW202005694A (zh) 2018-07-02 2020-02-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EP3826743A4 (en) 2018-07-25 2022-09-14 Merck Sharp & Dohme Corp. METHODS FOR SEPARATION OF HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC METHODS
KR20210045425A (ko) 2018-08-15 2021-04-26 브리스톨-마이어스 스큅 컴퍼니 하류 크로마토그래피에서의 재산화에 의한 단백질 단편화 제어 전략
WO2020096958A1 (en) 2018-11-05 2020-05-14 Bristol-Myers Squibb Company Method for purifying pegylated protein
WO2020172658A1 (en) 2019-02-24 2020-08-27 Bristol-Myers Squibb Company Methods of isolating a protein
US20220042954A1 (en) 2019-03-29 2022-02-10 Bristol-Myers Squibb Company Methods of measuring hydrophobicity of chromatographic resins
WO2020264411A1 (en) 2019-06-28 2020-12-30 Baxalta Incorporated Adeno-associated virus purification methods

Also Published As

Publication number Publication date
US20220308025A1 (en) 2022-09-29
PL3532838T3 (pl) 2022-10-03
ES2924060T3 (es) 2022-10-04
IL265874A (en) 2019-06-30
CN109923411A (zh) 2019-06-21
US10613063B2 (en) 2020-04-07
BR112019006689A2 (pt) 2019-06-25
EP4071469A3 (en) 2022-12-14
CA3039788A1 (en) 2018-05-03
US20230273163A1 (en) 2023-08-31
EP3532838B1 (en) 2022-06-01
HUE059631T2 (hu) 2022-12-28
MX2019004316A (es) 2019-08-05
JP2024028600A (ja) 2024-03-04
IL289895B (en) 2022-09-01
IL295211A (en) 2022-10-01
JP7102401B2 (ja) 2022-07-19
ZA201902257B (en) 2020-11-25
US20200191756A1 (en) 2020-06-18
EP4071469A2 (en) 2022-10-12
MX2023009744A (es) 2023-08-30
US11333642B2 (en) 2022-05-17
AU2017350807A1 (en) 2019-04-18
US11680930B2 (en) 2023-06-20
JP2022125254A (ja) 2022-08-26
SG11201902667UA (en) 2019-05-30
CN114858957A (zh) 2022-08-05
EP3532838A1 (en) 2019-09-04
AU2022246438A1 (en) 2022-11-03
KR20230119729A (ko) 2023-08-16
IL312194A (en) 2024-06-01
IL295211B1 (en) 2024-05-01
EA201990986A1 (ru) 2019-09-30
US20180113101A1 (en) 2018-04-26
DK3532838T3 (da) 2022-07-04
IL289895A (en) 2022-03-01
IL265874B (en) 2022-02-01
JP7427721B2 (ja) 2024-02-05
AU2017350807B2 (en) 2022-07-07
CN109923411B (zh) 2022-05-31
KR20190073396A (ko) 2019-06-26
JP2020500299A (ja) 2020-01-09
WO2018081203A1 (en) 2018-05-03
KR102564393B1 (ko) 2023-08-08

Similar Documents

Publication Publication Date Title
MX2023009744A (es) Metodos y sistemas para analisis de datos cromatograficos.
GB2571651B (en) Systems for predictive data analytics, and related methods and apparatus
WO2015138497A3 (en) Systems and methods for rapid data analysis
MX2017014659A (es) Metodos y sistemas para la deteccion de variantes del numero de copias.
MX2018001181A (es) Sistema y metodo para facilitar software de soldadura como un servicio.
MX2017003189A (es) Metodos de gestion de salud y bienestar y sistemas utiles para la practica de los mismos.
EP4343673A3 (en) Digital identification system
GB2556283A (en) Defect discrimination apparatus, methods, and systems
EP3171327A4 (en) Information processing device, method for generating control signal, information processing system, and program
EP3279804A4 (en) Data analysis system, data analysis method, data analysis program, and recording medium
MX2017015447A (es) Monitoreo de un sistema de transporte.
EP3506572A4 (en) FLOW INFORMATION ANALYZER, FLOW INFORMATION ANALYSIS METHOD AND FLOW INFORMATION ANALYZER PROGRAM
IN2015DE01249A (es)
PH12018500868A1 (en) Method, system, and device for process triggering
GB2548620B (en) A method, apparatus, computer program, chip set, or data structure for correlating a digital signal and a correlation code
IN2014MU00871A (es)
EP3298463A4 (en) METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR GNSS RECEIVER SIGNAL HEALTH AND SAFETY ANALYSIS
MX2016015953A (es) Sistema y metodo de recuperacion de informacion.
GB2540911A (en) Method and system for signal processing
GB201504548D0 (en) An apparatus, method and computer program for providing an audio signal
MX2018014113A (es) Aparato para determinar una información de similitud, método para determinar una información de semejanza, aparato para determinar una información de autocorrelación, aparato para determinar una información de correlación cruzada y programa de computadora.
SG11201810856RA (en) Method, device, and terminal device for extracting data
IL261819B (en) SYSTEM, METHOD, AND COMPUTER SOFTWARE PRODUCT FOR DATA PROCESSING
HK1249620A1 (zh) 用於基於生物特徵信息生成聲信號的系統，方法和裝置
GB201611377D0 (en) An apparatus, method and computer program for obtaining audio signals